AbCellera has announced a proposed public offering of common stock and pre-funded warrants, marking a significant capital-raising event for the publicly traded company. While the exact amount to be raised remains undisclosed, the offering follows AbCellera's successful IPO in December 2020. The company intends to use the net proceeds for general corporate purposes, including research and development, and potential strategic acquisitions.